Clinical Trials Browser

Giant Cell Tumor of Tendon Sheath × pexidartinib × Clear all

NCT04703322 2026-03-04

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Phase 2 Active not recruiting

9 enrolled 10 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT04635111 2025-10-06

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Giant Cell Tumor of Tendon Sheath

NCT04488822 2025-09-09

PLX3397

Phase 3 Active not recruiting

40 enrolled 15 charts

Giant Cell Tumor of Tendon Sheath

NCT04526704 2024-12-30

PLX3397

Phase 4 Completed

32 enrolled 15 charts

Giant Cell Tumor of Tendon Sheath

NCT02371369 2022-05-11

ENLIVEN

Phase 3 Completed

120 enrolled 25 charts 1 FDA

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT04223635 2021-06-22

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Phase EARLY_PHASE1 Completed

16 enrolled 22 charts

Giant Cell Tumor of Tendon Sheath